MARY LANE: Open Payments
NPI 1437596301 · LACEY, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,670 in 17 payments from 9 companies in 2025. Trend: 2023 $1,098 · 2024 $3,700 · 2025 $1,670
Food & beverage: $1,571Education: $99
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 6 | $651 |
| Regeneron Healthcare Solutions, Inc. | 2 | $175 |
| Adaptive Biotechnologies Corporation | 1 | $163 |
| BeOne Medicines USA, Inc. | 1 | $133 |
| Astellas Pharma US Inc | 1 | $130 |
| E.R. Squibb & Sons, L.L.C. | 1 | $121 |
| Alnylam Pharmaceuticals Inc. | 1 | $121 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $89 |
| ABBVIE INC. | 3 | $88 |
Products named: RYBREVANT, LIBTAYO, clonoSEQ, TEVIMBRA, Vyloy, OPDIVO, GIVLAARI, ERLEADA.
Industry payments across WA — which companies pay providers there.
